Join the 200th Anniversary Celebration

Correction

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

N Engl J Med 2004; 351:2461December 2, 2004

Article

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer (Original Article, N Engl J Med 2004:350;1081 - 1092) . On page 1083, in Figure 1, the number of patients who were assigned to receive two to three years of tamoxifen therapy should have read 2380, rather than 2362, as printed, and the number of patients assigned to receive exemestane therapy should have read 2362, rather than 2380, as printed.

Citing Articles (1)

Citing Articles

  1. 1

    Richard J. Santen. 2009. Breast Cancer. , 659-686.
    CrossRef